Menu
GeneBe

ROR2

receptor tyrosine kinase like orphan receptor 2, the group of Receptor tyrosine kinases|I-set domain containing

Basic information

Region (hg38): 9:91563090-91950228

Previous symbols: [ "NTRKR2", "BDB", "BDB1" ]

Links

ENSG00000169071NCBI:4920OMIM:602337HGNC:10257Uniprot:Q01974AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive Robinow syndrome (Supportive), mode of inheritance: AR
  • brachydactyly type B1 (Strong), mode of inheritance: AD
  • autosomal recessive Robinow syndrome (Strong), mode of inheritance: AR
  • autosomal recessive Robinow syndrome (Definitive), mode of inheritance: AR
  • brachydactyly type B1 (Definitive), mode of inheritance: AD
  • autosomal dominant Robinow syndrome 1 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Robinow syndrome, autosomal recessive 1ARCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Renal10700182; 10932186; 10932187; 10986040; 12919145; 15952209; 17256787; 18831060; 19461659; 22178368; 23238279; 24932600; 24954533; 26284319; 30143665; 31617258; 32172608

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ROR2 gene.

  • not provided (456 variants)
  • Autosomal recessive Robinow syndrome (138 variants)
  • Brachydactyly type B1 (123 variants)
  • Brachydactyly type B1;Autosomal recessive Robinow syndrome (49 variants)
  • Inborn genetic diseases (46 variants)
  • not specified (33 variants)
  • Autosomal recessive Robinow syndrome;Brachydactyly type B1 (26 variants)
  • Short stature (9 variants)
  • ROR2-related condition (6 variants)
  • Autosomal dominant Robinow syndrome 1 (3 variants)
  • Brachydactyly, type B1Robinow syndrome, autosomal recessive (2 variants)
  • Brachydactyly (2 variants)
  • Arthrogryposis multiplex congenita;Fetal akinesia deformation sequence 1 (1 variants)
  • Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita (1 variants)
  • ROR2-Related Disorders (1 variants)
  • Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly (1 variants)
  • Normal pregnancy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ROR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
104
clinvar
8
clinvar
121
missense
6
clinvar
195
clinvar
14
clinvar
9
clinvar
224
nonsense
10
clinvar
2
clinvar
12
start loss
0
frameshift
5
clinvar
1
clinvar
2
clinvar
8
inframe indel
4
clinvar
4
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
3
1
4
non coding
1
clinvar
29
clinvar
45
clinvar
32
clinvar
107
Total 17 10 239 163 49

Highest pathogenic variant AF is 0.0000197

Variants in ROR2

This is a list of pathogenic ClinVar variants found in the ROR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-91633776-TGTACATAGGCAGAACAGGTTACTGTAACAAGTAGAGACTGCTATGGAGATTTCATTAAGGTTGACACATTCATTTCAACTGGCCAGGAGCGTCAGACCATATCCCAGAACACTCAGGCATTCTCAAGTACTAACAAATAATCCCTGTAAATCACTCACTTCCACAAAAGTTTAAAATAAAAATAGAGGTAGAGGAATCTTTCTCCAACTTTTTCCTGATGCTCTTTTCTATTCTAGTGTGATCCTGCTCTATGTTTTCCAATCTCATCATTCTTGTTCATTGCTGGTCCACTCAGTCCTTTTAAGTCAACAGTTATAAGTGTGCTTACATTCTATTAGAATGAGATCTGATGACAGGGCTTATCTAAGGCTGAAGTCCCTCAAGGACTTCCCTTCCCCAATCTCTCTCACACATCAATAAGAGCCGCAGGAGTGGCTTTATTATGTGAATTTATTGTGCCTTCTCTTGAAGAATATCATCCAATGCTGTTTTAAAATTGTATCTTTCAAATGCCATTTGAAATGGTTATAAGGCATAGAACAATATAAGCTATGGCATTTGCTAATAAGCATTAGCATGGAGCCATATGCTCCCAAAATATATTACACTTTCCACAAAGAAGTCAGAGACAGAGTTTATCAAGGATAGATACCATACTTCTTTATTCCCTAATAGCTATAGCTATATCCTTAGGGTTCTATGCTATTTTTATTTTGAAACTCTTAAATATGCAGTCTATTTCATCCCATAAACATATTAAAGACTAAATTTACCACAGGTTGTCAGACTAGAAAAAGATGAATGAGACTCTCTAAAGGCAGGCAAGCTCACTAAAAAAATATTACCCAAATGAAAACTCTGGGCAACAGAATAGTAAAGCAACACTCTTTAATGTTACTTGATCATTTGGTCACTAATTCCAGAGGATATTTGGTAAAATGTTCAACAGATAATCTGTTAAATGAGATGAAAGCCTGGGTTTGAGAAATAAAAGTGCTCTCTAAAGTTGTTTGAGTGGAAACTGTAGGGAAATAATGAGAGAGAGAGAGAGAAGAAGAAGAAGAAAAGAAGAAGAAGAAGGAGAAGGAGAAGGAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGGAGAAAAAGAAGAAAAAGAGGAGAAGAAGAAGAAGTAGCAGAGGAGGGGAGGAGGAGAAGGAAGAGGCAGAGGAGGAAGAGGCGGAGGAGGAGGAAGAGGAGGGGGAGGAAGAAGAGGAGGGGGAGGAAGAGGAGGAGGAGGAGGAGAAAGAGATTACATGCCTGTAATCCTAGCACTTTGGGAGGCCGAGGCGGGTGGACTGCCTGAGCTCAGGAGTTTGAGACCAGCCTAGGCAACACGGTGAAACCCCGTCTCTACTAAAATACAAAAAAATTAGCCGGGCATGGCGGTGTGCACCTGTAATCCCAGTTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAAGCGGAGGTTGCAGTAAGCCAAGATTGCGCCATTGCACTTCAGCCTGGGCAACAGAGCAAGACTCCGTCTCAAAAAAAAAAAAAAATTGAATATTTTACCTCGTCTTAAGAGTTTCATGTCAATCTGGCCTTTATCCCTTTAAAAAGGGTCTTTCTTTTTTTTTTTTTAACTTCTCTCTGGGAGTTTCCAGAAACCTCTTTTTTCCTTTGGTGCTCATAAATTTAATGAGCATGTATATCAGTTGGGGCCATTTCTCATTCACTGCACTCAGGAATCAGCATGCCCTTTCAATAGGGGATTCATATCATTCAGCCCTGGGAATTTCCTTTAATTTTTTAAGAAATATAATTTTGGGCCAGGAGTAGCGGCTTATGCCTGTAATCCCAACACTTTGGGAGGTCGAGATAGGTGGATCACTTGAGGGCAGGAGTTCGAGACCAGCCTGGCCAACATGGCAAAACCTGTCTCTACTAAAAATACAAAAATTAGCTGGGCATGGTGGCAGGTGCCTGTGATCCCAGCTACTCAGGAGGCTGAGACAGGAGAATCCCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCAATATCACGCCATTGCACTCCAGCCTGGGTGACAGGAGCAAAACTCCATCTCAACAAAAAATAAATAAATAAATATAATTTTGTTCTCTTAATTTTCTCTGTTCACTCTTTCTGAAAAGCCTGATGAATTGGTTTTCTATACTTCCTTTGCTTCTCTAATATTTTCCTTCTTTTTGCTCTGACTCTAAGGAGCTCATTGGATTTTCCAGGCCTTCTATTGAAATTTTTTTTAAATCCTAATTTTTCTTTATTAAAGATCTCAGTTTTTTTGTCACATTTTTGTAACATCTTGCTCTTGTTATCTAGATATGTTTCCAAAATCTCTTTTAATTCATCAATTAAGGGGATTTTTAATGTCTTCGGATTCTCTTCTTCTTTTGCTGTCAGTTTTTCTGTTGCTTGTCTTGGTTTTATGCCTTTTATATCAAGGCACATAAAAGGCATAAAACCAAGACAAGCAACAAAAAAAGGATTGATCACAGAAGTTTCTCCTTATGTGCCAATTGGTCTTCAGTTGCTCAGTTCTAGTTAAATCAAAAGACCAGGGTGGCTGGTGTGGTTTCCTCTGCTGTTGAGAACATTAGTCTGTTTTCCATCAGTCTCACCACTGAATGGGAATTCTTGCTGGATGCTCTGGGCAGGGCAGGGCATGACAGGGCAAATAGACTGGTGGGCTTTCTTTGGGTAAG-T Normal pregnancy not provided (-)157151
9-91722646-A-C Brachydactyly type B1 • Autosomal recessive Robinow syndrome Benign (Jan 13, 2018)367479
9-91722735-G-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign/Likely benign (Jan 12, 2018)367480
9-91722776-C-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign (Jan 12, 2018)367481
9-91722896-A-G Brachydactyly • Autosomal dominant Robinow syndrome 1 Likely benign (Jun 14, 2016)367482
9-91722926-T-C Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign/Likely benign (Jun 01, 2021)367483
9-91722950-G-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign (May 14, 2021)367484
9-91722980-G-C Brachydactyly type B1 • Autosomal recessive Robinow syndrome Uncertain significance (Jan 13, 2018)367485
9-91723091-C-G Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Jan 13, 2018)914694
9-91723104-G-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Jan 13, 2018)367486
9-91723109-C-T Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Apr 27, 2017)914695
9-91723141-C-T Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign/Likely benign (Jan 13, 2018)367487
9-91723142-G-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Conflicting classifications of pathogenicity (Jan 13, 2018)367488
9-91723175-G-C Brachydactyly type B1 • Autosomal recessive Robinow syndrome Uncertain significance (Jan 13, 2018)367489
9-91723229-G-A Brachydactyly type B1 • Autosomal recessive Robinow syndrome Uncertain significance (Jan 13, 2018)976640
9-91723264-C-G Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Jan 13, 2018)913098
9-91723293-C-G Brachydactyly type B1 • Autosomal recessive Robinow syndrome Uncertain significance (Jan 12, 2018)913099
9-91723417-T-C Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign/Likely benign (Feb 28, 2021)367490
9-91723433-G-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 Benign/Likely benign (Nov 16, 2018)367491
9-91723482-G-T Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Jan 13, 2018)367492
9-91723486-GCTCT-G Brachydactyly • Autosomal dominant Robinow syndrome 1 Benign (Oct 16, 2018)367493
9-91723527-C-A Autosomal recessive Robinow syndrome • Brachydactyly type B1 • Brachydactyly type B1;Autosomal recessive Robinow syndrome Uncertain significance (Jan 26, 2022)367494
9-91723537-G-T Autosomal recessive Robinow syndrome • Brachydactyly type B1 Uncertain significance (Jan 12, 2018)914247
9-91723555-C-G Brachydactyly type B1 • Autosomal recessive Robinow syndrome Uncertain significance (Jan 13, 2018)914248
9-91723556-G-A Brachydactyly type B1 • Autosomal recessive Robinow syndrome Conflicting classifications of pathogenicity (Jan 13, 2018)914737

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ROR2protein_codingprotein_codingENST00000375708 9387072
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001241.001256840641257480.000255
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1435845940.9830.00004276118
Missense in Polyphen150189.350.79222087
Synonymous-3.003302681.230.00002141937
Loss of Function3.731439.20.3570.00000247385

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007970.000781
Ashkenazi Jewish0.0002980.000298
East Asian0.0001090.000109
Finnish0.0004930.000462
European (Non-Finnish)0.0002130.000202
Middle Eastern0.0001090.000109
South Asian0.0001960.000196
Other0.0003310.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development (By similarity). Phosphorylates YWHAB, leading to induction of osteogenesis and bone formation (PubMed:17717073). In contrast, has also been shown to have very little tyrosine kinase activity in vitro. May act as a receptor for wnt ligand WNT5A which may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443). {ECO:0000250|UniProtKB:Q9Z138, ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:25029443}.;
Disease
DISEASE: Brachydactyly B1 (BDB1) [MIM:113000]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. In brachydactyly type B1 the middle phalanges are short but in addition the terminal phalanges are rudimentary or absent. Both fingers and toes are affected. The thumbs and big toes are usually deformed. Symphalangism is also a feature. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Robinow syndrome autosomal recessive (RRS) [MIM:268310]: A recessive form of Robinow syndrome, a disease characterized by short-limb dwarfism, costovertebral segmentation defects and abnormalities of the head, face and external genitalia. The clinical signs are generally far more severe in recessive cases, particularly skeletal abnormalities. All patients with the recessive form suffer from vertebral segmentation abnormalities, resulting in scoliosis and chest deformities. Rib fusions are considered to be characteristic of the autosomal recessive form. Patients can also present brachydactyly, with extensive aplasia/hypoplasia of the phalanges and metacarpals/metatarsals, and brachy-syn-polydactyly of the hands and oligodactyly of the feet. {ECO:0000269|PubMed:10932186, ECO:0000269|PubMed:10932187}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
WNT-Ncore;TGF-Ncore;Cardiac Progenitor Differentiation;Ectoderm Differentiation;Wnt Signaling Pathway;Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;PCP/CE pathway;Beta-catenin independent WNT signaling;Noncanonical Wnt signaling pathway;Wnt;Wnt signaling network (Consensus)

Recessive Scores

pRec
0.110

Intolerance Scores

loftool
0.0625
rvis_EVS
-1.07
rvis_percentile_EVS
7.35

Haploinsufficiency Scores

pHI
0.188
hipred
Y
hipred_score
0.756
ghis
0.546

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.947

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ror2
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; skeleton phenotype;

Zebrafish Information Network

Gene name
ror2
Affected structure
head
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
cartilage condensation;somitogenesis;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;Wnt signaling pathway, calcium modulating pathway;smoothened signaling pathway;JNK cascade;multicellular organism development;negative regulation of cell population proliferation;astrocyte development;peptidyl-tyrosine phosphorylation;bone mineralization;positive regulation of cell migration;BMP signaling pathway;embryonic genitalia morphogenesis;male genitalia development;inner ear morphogenesis;embryonic digit morphogenesis;positive regulation of JUN kinase activity;cell fate commitment;positive regulation of macrophage differentiation;positive regulation of transcription, DNA-templated;anatomical structure development;positive regulation of synaptic transmission, glutamatergic;Wnt signaling pathway, planar cell polarity pathway;SMAD protein signal transduction;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;positive regulation of protein kinase C activity;macrophage migration
Cellular component
microtubule;plasma membrane;integral component of plasma membrane;cell surface;axon;dendrite;clathrin-coated endocytic vesicle membrane;neuronal cell body;receptor complex
Molecular function
transmembrane receptor protein tyrosine kinase activity;frizzled binding;protein binding;ATP binding;Wnt-protein binding;mitogen-activated protein kinase kinase kinase binding;metal ion binding;coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway